Sona’s Gold Nanorods will redefine the next generation of lateral flow test development.
Sona’s unique gold nanorod technology combines the benefits of multicoloured nanoparticles with the performance and ease of use of traditional spherical gold to power your next generation lateral flow assays.
Lateral Flow Assay is an immunochromatographic assay for the qualitative detection of the spike protein antigen from SARS-CoV-2 in nasopharyngeal (NP) swab specimens from individuals who are suspected of COVID-19.
Lateral Flow Test Development
Sona provides a tailored, modular contract development service from proof of concept through to full development and transfer to production, helping you bring your tests to market.
Sona can combine your biologicals with our nanorods to offer a fully optimized conjugate for your assays, reducing your development time and allowing you to focus on test development.
Lateral Flow Test Production
Sona is partnered with world-class, third-party manufacturers to manufacture pilot and validation batches through to large-scale bulk volumes to serve your market.
Lateral Flow Test Reader
The ‘Cube’ is the next generation of test readers – small, compact, user-friendly, intuitive, wireless, cost-effective and provides clear results. It serves as a virtual ‘electronic eye’ to turn qualitative tests into quantitative tests.
High-quality, high-yield gold nanorods synthesized without CTAB